Interspecies scaling of biliary excreted drugs

作者: Iftekhar Mahmood , Chandra Sahajwalla

DOI: 10.1002/JPS.10174

关键词:

摘要: Abstract The objective of this study is to predict clearance drugs in humans from animals which are excreted the bile. Clearance ( CL ) eight known be bile were randomly selected literature. Scaling was performed using at least three animal species. Using simple allometry,  × mean life‐span potential (MLP) or  × brain weight, s studied predicted humans. choice one methods depended on ‘rule exponents' as described by Mahmood and Balian. A ‘correction factor' calculated adjusting flow rate based species body weight (bile flow = mL/day/kg weight) liver weight). combining it with factor', biliary Predicted allometry several times higher for all (% error [range] = 46–1703). a report provided substantial improvement [range] = 5–91) prediction drugs. results indicate that drug may overpredicted applying employed here, predictability data significantly improved. © 2002 Wiley‐Liss, Inc. American Pharmaceutical Association J Pharm Sci 91:1908–1914,

参考文章(22)
G Kühne, B Düsterberg, U Täuber, Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals. Drug Research. ,vol. 36, pp. 1187- 1190 ,(1986)
Brian Davies, Tim Morris, Physiological Parameters in Laboratory Animals and Humans Pharmaceutical Research. ,vol. 10, pp. 1093- 1095 ,(1993) , 10.1023/A:1018943613122
Ingrid Påhlman, Sari Kankaanranta, Monica Edholm, Marie‐Louise Odell, Pharmacokinetics of Susalimod, a Highly Biliary‐excreted Sulphasalazine Analogue, in Various Species. Nonpredictable Human Clearance by Allometric Scaling Pharmacy and Pharmacology Communications. ,vol. 4, pp. 493- 498 ,(1998) , 10.1111/J.2042-7158.1998.TB00661.X
S Tulebaev, N Gerber, E Iatsimirskaia, I Utkin, T Koudriakova, D Mullet, D Spetie, T Thompson, P Vouros, In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats. Journal of Pharmacology and Experimental Therapeutics. ,vol. 279, pp. 1300- 1309 ,(1996)
K Nakagawa, M Koyama, H Matsui, C Ikeda, K Yano, N Nakatsuru, K Yoshinaga, T Noguchi, Pharmacokinetics of cefpiramide (SM-1652) in humans. Antimicrobial Agents and Chemotherapy. ,vol. 25, pp. 221- 225 ,(1984) , 10.1128/AAC.25.2.221
Iftekhar Mahmood, INTERSPECIES SCALING OF RENALLY SECRETED DRUGS Life Sciences. ,vol. 63, pp. 2365- 2371 ,(1998) , 10.1016/S0024-3205(98)00525-6
Yasufumi Sawada, Manabu Hanano, Yuichi Sugiyama, Tatsuji Iga, Prediction of the disposition of β -lactam antibiotics in humans from pharmacokinetic parameters in animals Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 12, pp. 241- 261 ,(1984) , 10.1007/BF01061720
Harold Boxenbaum, Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm Drug Metabolism Reviews. ,vol. 15, pp. 1071- 1121 ,(1984) , 10.3109/03602538409033558
J. L. Maggs, S. F. M. Grimmer, M. L'E. Orme, A. M. Breckenridge, B. K. Park, I. T. Gilmore, The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women. Xenobiotica. ,vol. 13, pp. 421- 431 ,(1983) , 10.3109/00498258309052280
H Matsui, K Yano, T Okuda, Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys. Antimicrobial Agents and Chemotherapy. ,vol. 22, pp. 213- 217 ,(1982) , 10.1128/AAC.22.2.213